MUSH oatmeal products displayed on a wooden table. - CNBC Ambition / YouTube Americans regularly consume too much sugar. It's estimated that adult men consume 19 teaspoons of added sugar daily, while ...

Upcoming variety show “Chef of Antarctica” (literal title) has shared a sneak peek at the upcoming show! The newly released teaser begins with the beautiful scenery of Antarctica, showing glaciers, ...

We may earn commission from links on this page, but we only recommend products we love. Promise. Whether it was the joy of seeing the pen swirl round and round to create a spiral or all the wild ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween +hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted hits as ...

President Donald Trump said he'd be willing to extend his trip abroad to Asia if North Korea's Kim Jong Un wants to meet with him. "But I'd love to meet with him if he'd like to meet. I got along ...

Everyone from Sabrina Carpenter to Malala Yousafzai is lip-syncing on TikTok to an unexpected remix mashing up Nicki Minaj’s hit “Beez in the Trap” with 4 Non Blondes’ ‘90’s classic, “What’s Up,” ...

Trump administration officials have privately discussed setting up a meeting between President Donald Trump and North Korean leader Kim Jong Un when Trump visits Asia next month, though many are ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

Barcelona announced Frenkie de Jong signed a new long-term contract with the club through 2029, putting an end to years of speculation regarding his future. “Frenkie de Jong will continue to wear the ...

If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Roche has scooped up 89bio and its phase III FGF21 analogue pegozafermin, as drug developers continue to race to advance new drugs for the liver disease metabolic dysfunction-associated ...